[조사자료] 세계의 펩타이드 치료제 시장 2024-2030 : 용도별 (암, 대사 장애), 유형별 (제네릭, 혁신형), 제조사별, 투여 경로별, 합성 기술별, 지역별

■ 영문 제목 : Peptide Therapeutics Market Size, Share & Trends Analysis Report By Application (Cancer, Metabolic Disorders), By Type (Generic, Innovative), By Type of Manufacturer, By Route of Administration, By Synthesis Technology, By Region, And Segment Forecasts, 2024 - 2030
	■ 상품코드 : GRV24JAN166 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 11월 ■ 페이지수 : 110 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 펩타이드 치료제 시장의 성장과 동향
Grand View Research, Inc.사의 새로운 보고서에 따르면, 세계의 펩타이드 치료제 시장 규모는 2030년까지 664억1000만 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 6.1%의 CAGR을 기록할 것으로 전망됩니다. 암 및 기타 생활습관병 치료를 위해 부작용이 적고 효율적이고 즉각적인 치료제에 대한 수요가 증가하면서 시장 성장을 촉진할 것으로 예상됩니다. 암 발병률의 증가로 인해 다른 치료법 및 저비용 치료법의 모색과 도입이 요구되고 있으며, 이는 시장 성장을 견인할 것으로 예상됩니다. 또한, 노인 인구의 증가는 암, 당뇨병 등 대상 질환의 이환율을 유발하여 소비자 기반을 확대할 것으로 예상되며, 펩타이드 치료제의 수요를 촉진할 것으로 기대됩니다.

국제암연구소(GLOBOCAN 2020) 보고서에 따르면, 2020년 전 세계적으로 19,292,789명이 새롭게 암 진단을 받고 9,958,133명이 사망할 것으로 예상됩니다. 또한, 암의 5년 유병률은 전 세계적으로 50,550,287명이 될 것으로 예상되며, 2040년에는 전 세계 신규 암 환자 수가 28,887,940명에 달할 것으로 예측됩니다. 이에 따라 전 세계적으로 증가하는 암 발생률은 예측 기간 동안 펩타이드 치료제 개발에 중요한 역할을 할 것으로 보입니다. 또한, 화학요법과 방사선 치료의 부작용에 대한 의료진과 환자들의 인식이 높아지면서 펩타이드 기반 약물과 같은 대체 치료법에 대한 관심이 높아지는 것도 주요 요인으로 작용하고 있습니다.

펩타이드 제조 공정의 기술 발전은 예측 기간 동안 시장을 주도하고 있습니다. 제조업체와 공급업체는 적은 시간과 자본 투자로 효율적인 약물 분자를 생산하기 위해 새로운 기술을 채택하는 데 주력하고 있습니다. 정제 및 자동화 공정의 개선과 폐기물 발생 감소도 시장 성장의 또 다른 요인입니다. 예를 들어, 암젠은 2022년 3월 노스캐롤라이나주 홀리스프링스에 최신 바이오 제조 시설을 정식으로 오픈한다고 발표했으며, 이 시설은 암젠의 암, 심장병 등 심각한 질병을 치료하는 의약품의 성장에 대응하는 데 도움이 될 것으로 예상됩니다.

코로나19 팬데믹은 진단 지연, 치료 개입, 암 치료를 위한 비용 효율적인 치료제 개발에 초점을 맞춘 임상 시험의 억제 등 암 치료의 스펙트럼에 박차를 가할 것으로 예상되며, 암 치료를 위한 펩타이드 치료제도 예외는 아니다. 2020년 5월 현재 코로나19 치료를 위한 21개의 펩타이드 의약품이 있는데, 여기에는 급성호흡곤란증후군(ARDS) 및 중증 급성 호흡기 감염으로 인한 기타 호흡기 질환 치료를 위한 15개의 합성 펩타이드가 포함돼 있습니다. 그러나 암, 대사성 질환 등에서 펩타이드 치료제의 실용화는 약물 부족과 운영상의 문제, 코로나19 이외의 치료제 임상 시험 지연 등이 걸림돌로 작용하고 있습니다.

예를 들어, 지난 5월 EVER Pharma는 보르테조밉(bortezomib)이 증상성 골수종 및 맨틀세포 림프종 치료제로 EU 전역에서 승인을 받았다고 발표했습니다.1 지난 5월 유럽위원회는 노바티스의 급성 및 만성 이식편대숙주질환에 대한 스테로이드 후 치료제로서 자카비(Jakavi)를 승인했습니다. 2021년 9월, Nimble Therapeutics와 Incyte는 새로운 펩타이드 치료제 발굴을 위한 전략적 협력을 시작했습니다. 전략적 공동연구를 시작했습니다.

펩타이드 치료제 시장 보고서 주요 내용

- 용도별로는 2023년 암이 기존 치료제보다 대체 치료법에 대한 수요가 증가함에 따라 암이 두 번째로 높은 매출 점유율을 차지할 것으로 예상됩니다. 펩타이드는 암 치료에서 잠재적인 치료제로 사용되고 있습니다.

- 제네릭 의약품 분야는 블록버스터 펩타이드의 특허 만료와 정부의 적극적인 제네릭 의약품 도입 정책으로 인해 매출이 증가할 것으로 예상됩니다.

- 아웃소싱 제조 분야는 복잡한 절차에 대한 요구와 제조 비용 절감에 도움이 되는 아웃소싱에 대한 선호도 변화로 인해 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.

- 합성 기술별로는 하이브리드 기술이 예측 기간 동안 가장 빠른 성장을 보일 것으로 예상됩니다. 고상 및 액상 펩타이드 합성에서 시간 절약 및 사용 편의성 등 이 기술과 관련된 이점이 성장을 촉진하는 주요 요인으로 꼽히고 있습니다.

- 북미는 유전체학 및 프로테오믹스 제품에 대한 높은 인지도, 확립된 R&D 인프라, 자금 조달 이니셔티브의 증가로 인해 2023년 매출에서 가장 큰 점유율을 차지할 것으로 예상되고 있습니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 펩타이드 치료제 시장 변수, 동향 및 범위
4. 세계의 펩타이드 치료제 시장 규모 : 용도별 세그먼트 분석, 2018 – 2030
5. 세계의 펩타이드 치료제 시장 규모 : 유형별 세그먼트 분석, 2018 – 2030
6. 세계의 펩타이드 치료제 시장 규모 : 제조 업체 유형별 세그먼트 분석, 2018 – 2030
7. 세계의 펩타이드 치료제 시장 규모 : 투여 경로별 세그먼트 분석, 2018 – 2030
8. 세계의 펩타이드 치료제 시장 규모 : 합성 기술별 세그먼트 분석, 2018 – 2030
9. 세계의 펩타이드 치료제 시장 규모 : 지역별 예측 및 동향 분석
10. 경쟁 현황
11. 결론

■ 보고서 목차

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Regional Scope
1.1.2 Market Definitions
1.1.3 Estimates and Forecast Timeline
1.2 Objectives
1.2.1 Objective – 1
1.2.2 Objective – 2
1.2.3 Objective – 3
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.8 List of Secondary Sources
1.9 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Application Segment Snapshot
2.3 Type and Type of Manufacturers Segment Snapshot
2.4 Route of Administration and Synthesis Technology Segment Snapshot
2.5 Competitive Landscape Snapshot
Chapter 3 Peptide Therapeutics Market Variables, Trends, and Scope
3.1 Peptide Therapeutics Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Incidence of Cancer
3.2.1.1.1 Cancer Incidence Data
3.2.1.2 Rising Prevalence of Metabolic Disorders
3.2.1.3 Presence of Strong Product Pipeline
3.2.1.4 Technological Advancements
3.2.2 Market Restraint Analysis
3.2.2.1 Increasing Complexity of Peptides
3.2.2.2 High Cost of Manufacturing Equipment
3.3 Peptide Therapeutics Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 PESTLE Analysis
Chapter 4 Peptide Therapeutics Market – Segment Analysis, by Application, 2018 – 2030 (USD Million)
4.1 Peptide Therapeutics Market: Application Movement Analysis
4.2 Peptide Therapeutics Market Estimates & Forecast, By Application (USD Million)
4.2.1 Cancer
4.2.2 Metabolic Disorders
4.2.3 Cardiovascular Disorders
4.2.4 Respiratory Disorders
4.2.5 Gastrointestinal Disorders
4.2.6 Infectious Diseases
4.2.7 Pain
4.2.8 Dermatological Disorders
4.2.9 Neurological Disorders
4.2.10 Renal Disorders
4.2.11 Others
Chapter 5 Peptide Therapeutics Market: Segment Analysis, by Type, 2018 – 2030 (USD Million)
5.1 Peptide Therapeutics Market: Type Movement Analysis
5.2 Peptide Therapeutics Market Estimates & Forecast, by Type (USD Million)
5.2.1 Generic
5.2.2 Innovative
Chapter 6 Peptide Therapeutics Market: Segment Analysis, By Type Of Manufacturers, 2018 – 2030 (USD Million)
6.1 Peptide Therapeutics Market: Type of Manufacturers Movement Analysis
6.2 Peptide Therapeutics Market Estimates & Forecast, by Type Of Manufacturers (USD Million)
6.2.1 In-house
6.2.2 Outsourced
Chapter 7 Peptide Therapeutics Market: Segment Analysis, by Route Of Administration, 2018 – 2030 (USD Million)
7.1 Peptide Therapeutics Market: Route Of Administration Movement Analysis
7.2 Peptide Therapeutics Market Estimates & Forecast, by Route Of Administration (USD Million)
7.2.1 Parenteral Route
7.2.2 Oral Route
7.2.3 Pulmonary
7.2.4 Mucosal
7.2.5 Others
Chapter 8 Peptide Therapeutics Market – Segment Analysis, by Synthesis Technology, 2018 – 2030 (USD Million)
8.1 Peptide Therapeutics Market: Synthesis Technology Movement Analysis
8.2 Peptide Therapeutics Market Estimates & Forecast, By Synthesis Technology (USD Million)
8.2.1 Solid Phase Peptide Synthesis (SPPS)
8.2.2 Liquid Phase Peptide Synthesis (LPPS)
8.2.3 Hybrid Technology
Chapter 9 Peptide Therapeutics Market: Regional Estimates and Trend Analysis by Application, Type, Type of Manufacturer, Route of Administration, and Synthesis Technology
9.1 Peptide Therapeutics Market: Regional Outlook
9.2 North America
9.2.1 North America Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 Target Disease Prevalence
9.2.2.3 U.S. Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.2.4 Competitive/Market Scenario
9.2.2.5 Regulatory Framework
9.2.2.6 Reimbursement Scenario
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Target Disease Prevalence
9.2.3.3 Canada Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.2.3.4 Competitive/Market Scenario
9.2.3.5 Regulatory Framework
9.2.3.6 Reimbursement Scenario
9.3 Europe
9.3.1 Europe Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.2 UK
9.3.2.1 Key Country Dynamics
9.3.2.2 Target Disease Prevalence
9.3.2.3 UK Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.2.4 Competitive/Market Scenario
9.3.2.5 Regulatory Framework
9.3.2.6 Reimbursement Scenario
9.3.3 Germany
9.3.3.1 Key Country Dynamics
9.3.3.2 Target Disease Prevalence
9.3.3.3 Germany Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.3.4 Competitive/Market Scenario
9.3.3.5 Regulatory Framework
9.3.3.6 Reimbursement Scenario
9.3.4 France
9.3.4.1 Key Country Dynamics
9.3.4.2 Target Disease Prevalence
9.3.4.3 France Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.4.4 Competitive/Market Scenario
9.3.4.5 Regulatory Framework
9.3.4.6 Reimbursement Scenario
9.3.5 Spain
9.3.5.1 Key Country Dynamics
9.3.5.2 Target Disease Prevalence
9.3.5.3 Spain Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.5.4 Competitive/Market Scenario
9.3.5.5 Regulatory Framework
9.3.5.6 Reimbursement Scenario
9.3.6 Italy
9.3.6.1 Key Country Dynamics
9.3.6.2 Target Disease Prevalence
9.3.6.3 Italy Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.6.4 Competitive/Market Scenario
9.3.6.5 Regulatory Framework
9.3.6.6 Reimbursement Scenario
9.3.7 Denmark
9.3.7.1 Key Country Dynamics
9.3.7.2 Target Disease Prevalence
9.3.7.3 Denmark Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.7.4 Competitive/Market Scenario
9.3.7.5 Regulatory Framework
9.3.7.6 Reimbursement Scenario
9.3.8 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Target Disease Prevalence
9.3.8.3 Sweden Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.8.4 Competitive/Market Scenario
9.3.8.5 Regulatory Framework
9.3.8.6 Reimbursement Scenario
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Target Disease Prevalence
9.3.9.3 Norway Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.3.9.4 Competitive/Market Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.3.9.7 Rest of Europe Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Target Disease Prevalence
9.4.2.3 Japan Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.2.4 Competitive/Market Scenario
9.4.2.5 Regulatory Framework
9.4.2.6 Reimbursement Scenario
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 Target Disease Prevalence
9.4.3.3 China Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.3.4 Competitive/Market Scenario
9.4.3.5 Regulatory Framework
9.4.3.6 Reimbursement Scenario
9.4.4 India
9.4.4.1 Key Country Dynamics
9.4.4.2 Target Disease Prevalence
9.4.4.3 India Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.4.4 Competitive/Market Scenario
9.4.4.5 Regulatory Framework
9.4.4.6 Reimbursement Scenario
9.4.5 Australia
9.4.5.1 Key Country Dynamics
9.4.5.2 Target Disease Prevalence
9.4.5.3 Australia Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.5.4 Competitive/Market Scenario
9.4.5.5 Regulatory Framework
9.4.6 Thailand
9.4.6.1 Key Country Dynamics
9.4.6.2 Thailand Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.6.3 Competitive/Market Scenario
9.4.6.4 Regulatory Framework
9.4.6.5 Reimbursement Scenario
9.4.7 South Korea
9.4.7.1 Key Country Dynamics
9.4.7.2 South Korea Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.7.3 Competitive/Market Scenario
9.4.7.4 Regulatory Framework
9.4.7.5 Reimbursement Scenario
9.4.8 Rest of Asia Pacific Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5 Latin America
9.5.1 Latin America Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Target Disease Prevalence
9.5.2.3 Brazil Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.5.2.4 Competitive/Market Scenario
9.5.2.5 Regulatory Framework
9.5.2.6 Reimbursement Scenario
9.5.3 Mexico
9.5.3.1 Key Country Dynamics
9.5.3.2 Target Disease Prevalence
9.5.3.3 Mexico Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.5.3.4 Competitive/Market Scenario
9.5.3.5 Regulatory Framework
9.5.3.6 Reimbursement Scenario
9.5.4 Argentina
9.5.4.1 Key Country Dynamics
9.5.4.2 Target Disease Prevalence
9.5.4.3 Argentina Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.5.4.4 Competitive/Market Scenario
9.5.4.5 Regulatory Framework
9.5.4.6 Reimbursement Scenario
9.5.5 Rest of Latin America Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.6 MEA
9.6.1 MEA Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 Target Disease Prevalence
9.6.2.3 South Africa Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.6.2.4 Competitive/Market Scenario
9.6.2.5 Regulatory Framework
9.6.2.6 Reimbursement Scenario
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Target Disease Prevalence
9.6.3.3 Saudi Arabia Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.6.3.4 Competitive/Market Scenario
9.6.3.5 Regulatory Framework
9.6.3.6 Reimbursement Scenario
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 Target Disease Prevalence
9.6.4.3 UAE Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.6.4.4 Competitive/Market Scenario
9.6.4.5 Regulatory Framework
9.6.4.6 Reimbursement Scenario
9.6.5 Kuwait
9.6.5.1 Key Country Dynamics
9.6.5.2 Target Disease Prevalence
9.6.5.3 Kuwait Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
9.6.5.4 Competitive/Market Scenario
9.6.5.5 Regulatory Framework
9.6.5.6 Reimbursement Scenario
9.6.5.7 Rest of MEA Peptide Therapeutics Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Strategy Mapping
10.2.1 New Product Launch
10.2.2 Partnerships
10.2.3 Acquisition
10.2.4 Collaboration
10.2.5 Funding
10.3 Key Company Market Share Analysis, 2023
10.4 Company Profiles
10.4.1 Eli Lilly and Company
10.4.1.1 Company overview
10.4.1.2 Financial performance
10.4.1.3 Product benchmarking
10.4.1.4 Strategic initiatives
10.4.2 Pfizer Inc.
10.4.2.1 Company overview
10.4.2.2 Financial performance
10.4.2.3 Product benchmarking
10.4.2.4 Strategic initiatives
10.4.3 Amgen Inc.
10.4.3.1 Company overview
10.4.3.2 Financial performance
10.4.3.3 Product benchmarking
10.4.3.4 Strategic initiatives
10.4.4 Takeda Pharmaceutical Company Limited
10.4.4.1 Company overview
10.4.4.2 Financial performance
10.4.4.3 Product benchmarking
10.4.4.4 Strategic initiatives
10.4.5 Sanofi
10.4.5.1 Company overview
10.4.5.2 Financial performance
10.4.5.3 Product benchmarking
10.4.5.4 Strategic initiatives
10.4.6 AstraZeneca
10.4.6.1 Company overview
10.4.6.2 Financial performance
10.4.6.3 Product benchmarking
10.4.6.4 Strategic initiatives
10.4.7 Teva Pharmaceutical Industries Ltd.
10.4.7.1 Company overview
10.4.7.2 Financial performance
10.4.7.3 Product benchmarking
10.4.7.4 Strategic initiatives
10.4.8 F. Hoffmann-La Roche Ltd
10.4.10.1 Company overview
10.4.10.2 Financial performance
10.4.10.3 Product benchmarking
10.4.10.4 Strategic initiatives
10.4.9 Novartis AG
10.4.9.1 Company overview
10.4.9.2 Financial performance
10.4.9.3 Product benchmarking
10.4.9.4 Strategic initiatives
10.4.10 Novo Nordisk A/S
10.4.10.1 COMPANY OVERVIEW
10.4.10.2 Product benchmarking
10.4.10.3 Strategic initiatives
10.4.11 GlaxoSmithKline plc.
10.4.11.1 Company overview
10.4.11.2 Product benchmarking
10.4.11.3 Strategic initiatives
10.4.12 Ironwood Pharmaceuticals, Inc.
10.4.12.1 Company overview
10.4.12.2 Product benchmarking
10.4.12.3 Strategic initiatives
10.4.13 Radius Health, Inc.
10.4.13.1 Company overview
10.4.13.2 Cepheid
10.4.13.3 Financial performance
10.4.13.4 Product benchmarking
10.4.13.5 Strategic initiatives
10.4.14 Ipsen Pharma
10.4.14.1 Company overview
10.4.14.2 Cepheid
10.4.14.3 Financial performance
10.4.14.4 Product benchmarking
10.4.14.5 Strategic initiatives
Chapter 11 Conclusion

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 4 North America peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 5 North America peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 6 North America peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 7 North America peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 8 North America peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 9 U.S. peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 10 U.S. peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 11 U.S. peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 12 U.S. peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 13 U.S. peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 14 Canada peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 15 Canada peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 16 Canada peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 17 Canada peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 18 Canada peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 19 Europe peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 20 Europe peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 21 Europe peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 22 Europe peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 23 Europe peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 24 Europe peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 25 UK peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 26 UK peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 27 UK peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 28 UK peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 29 UK peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 30 Germany peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 31 Germany peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 32 Germany peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 33 Germany peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 34 Germany peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 35 France peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 36 France peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 37 France peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 38 France peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 39 France peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 40 Spain peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 41 Spain peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 42 Spain peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 43 Spain peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 44 Spain peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 45 Italy peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 46 Italy peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 47 Italy peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 48 Italy peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 49 Italy peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 50 Denmark peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 51 Denmark peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 52 Denmark peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 53 Denmark peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 54 Denmark peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 55 Sweden peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 56 Sweden peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 57 Sweden peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 58 Sweden peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 59 Sweden peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 60 Norway peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 61 Norway peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 62 Norway peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 63 Norway peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 64 Norway peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 65 Asia Pacific peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 66 Asia Pacific peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 67 Asia Pacific peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 68 Asia Pacific peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 69 Asia Pacific peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 70 Asia Pacific peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 71 Japan peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 72 Japan peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 73 Japan peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 74 Japan peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 75 Japan peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 76 China peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 77 China peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 78 China peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 79 China peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 80 China peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 81 India peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 82 India peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 83 India peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 84 India peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 85 India peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 86 South Korea peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 87 South Korea peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 88 South Korea peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 89 South Korea peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 90 South Korea peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 91 Australia peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 92 Australia peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 93 Australia peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 94 Australia peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 95 Australia peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 96 Thailand peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 97 Thailand peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 98 Thailand peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 99 Thailand peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 100 Thailand peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 101 Latin America peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 102 Latin America peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 103 Latin America peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 104 Latin America peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 105 Latin America peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 106 Latin America peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 107 Brazil peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 108 Brazil peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 109 Brazil peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 110 Brazil peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 111 Brazil peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 112 Mexico peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 113 Mexico peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 114 Mexico peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 115 Mexico peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 116 Mexico peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 117 Argentina peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 118 Argentina peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 119 Argentina peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 120 Argentina peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 121 Argentina peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 122 MEA peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 123 MEA peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 124 MEA peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 125 MEA peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 126 MEA peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 127 MEA peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 128 South Africa peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 129 South Africa peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 130 South Africa peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 131 South Africa peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 132 South Africa peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 133 UAE peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 134 UAE peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 135 UAE peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 136 UAE peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 137 UAE peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 138 Saudi Arabia peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 139 Saudi Arabia peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 140 Saudi Arabia peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 141 Saudi Arabia peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 142 Saudi Arabia peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 143 Kuwait peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 144 Kuwait peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 145 Kuwait peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 146 Kuwait peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 147 Kuwait peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)

※본 조사보고서 [세계의 펩타이드 치료제 시장 2024-2030 : 용도별 (암, 대사 장애), 유형별 (제네릭, 혁신형), 제조사별, 투여 경로별, 합성 기술별, 지역별] (코드 : GRV24JAN166) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 펩타이드 치료제 시장 2024-2030 : 용도별 (암, 대사 장애), 유형별 (제네릭, 혁신형), 제조사별, 투여 경로별, 합성 기술별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 세포 침투 펩타이드 (CPP) 시장 2024-2030 : 단백질 유래 CPP, 합성 CPP, 키메라 CPP
GRV24JNU119 / Grand View Research / 2023년 12월 / 글로벌 세포 침투 펩타이드 (CPP) 시장의 성장 및 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 세포 투과성 펩타이드 시장 규모는 2024년부터 2030년까지 연평균 10.08% 성장하여 2030년에는 28.5억 달러에...1. 조사 방법 및 범위 2. 개요 3. 세계의 세포 침투 펩타이드 (CPP) 시장 변수, 동향, 범위 4. 세계의 세포 침투 펩타이드 (CPP) 시장 규모 : 유형별 비즈니스 분석 5. 세계의 세포 침투 펩타이드 (CPP) 시장 규모 : 응별용 비즈니스 분석 6. 세계의 세포 침투 펩타이드 (CPP) 시장 규모 :...

세계의 미생물 API 시장 2023-2030 : 호스별 (포유류, 박테리아, 곰팡이), 유형별 (항체, 펩타이드, 단백질), 부위별, 분자별, 최종 용도별, 지역별
GRV24JAN164 / Grand View Research / 2023년 11월 / 글로벌 미생물 API 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 미생물 API 시장 규모는 2030년까지 961억1000만 달러에 달할 것으로 예상되며, 2023년에서 2030년까지 6.66%의 CAGR을 기록할 것으로...1. 조사 방법 및 범위 2. 개요 3. 세계의 미생물 API 시장 변수/동향/범위 4. 세계의 미생물 API 시장 규모 : 호스트별 비즈니스 분석 5. 세계의 미생물 API 시장 규모 : 유형별 비즈니스 분석 6. 세계의 미생물 API 시장 규모 : 사이트별 비즈니스 분석 7. 세계의 미생물 API 시장 규모 :...

글로벌 펩티드 약물 복합체 시장 (2023-2030) : 루테튬, 멜플루펜, ANG1005, BT1718, CBX-12, 기타 파이프 라인
GRV23NOV280 / Grand View Research / 2023년 9월 / 글로벌 펩타이드 약물 복합체 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 펩타이드 약물 복합체 시장은 2030년까지 42억 1000만 달러에 달할 것으로 예상되며, 예측 기간 동안 28. 58%의...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 펩티드 약물 복합체 시장 : 유형별 예측 및 동향 분석 Chapter 5. 세계의 펩티드 약물 복합체 시장 : 제품별 예측 및 동향 분석 Chapter 6. 세계의 펩티드 약물 복합체 시장 : 지역별...

세계의 디지털 치료 (DTx) 시장 2024-2030 : 용도별 (당뇨병, 비만, 금연, 호흡기 질환), 최종 용도별 (환자, 의료 제공자, 지불자, 고용주), 지역별
GRV24JAN082 / Grand View Research / 2023년 11월 / 글로벌 디지털 치료 (DTx) 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 디지털 치료 (DTx) 시장 규모는 2024년부터 2030년까지 연평균 27.2%의 성장률을 보이며 2030년까지 325억 달러에 달할...1. 조사 방법 및 범위 2. 개요 3. 세계의 디지털 치료 (DTx) 시장 변수, 동향 및 범위 4. 세계의 디지털 치료 (DTx) 시장 규모 : 용도별 예측 및 동향 분석 5. 세계의 디지털 치료 (DTx) 시장 규모 : 최종 용도별 예측 및 동향 분석 6. 세계의 디지털 치료 (DTx) 시장...

세계의 mRNA 치료제 시장 2024-2030 : 희귀 유전 질환, 암, 호흡기 질환, 전염병
GRV24MAY130 / Grand View Research / 2024년 4월 / 글로벌 mRNA 치료제 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 mRNA 치료제 시장 규모는 2030년까지 313억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 17. 05%의 CAGR로 확대될 것으로...1. 조사 방법 및 범위 2. 개요 3. 시장 변수, 동향, 범위 4. 세계의 mRNA 치료제 시장 용도별 비즈니스 분석 5. 세계의 mRNA 치료제 시장 유형별 비즈니스 분석 6. 세계의 mRNA 치료제 시장 최종 용도별 비즈니스 분석 7. 세계의 mRNA 치료제 시장 용도별, 유형별, 최종 용도별 지역 비즈니스 분석 8....